Post by Invenra

We’re excited to welcome Nancy J. Sandy to Invenra as Chief Commercial Officer! Nancy joins us at a pivotal moment of growth as we expand our multispecific antibody platform portfolio, including our B-Body® bispecific and T-Body™ trispecific antibody technologies. We look forward to the leadership and commercial expertise she brings as we continue advancing next-generation antibody therapeutics. https://lnkd.in/g4KGJ2sz